The Inflation Reduction Act Will Cut Health Care Costs for Tennesseans
President Biden believes that health care should be a right, not a privilege. Every American
deserves the peace of mind that quality, affordable health insurance brings, and Americans
facing illness should never have to worry about how they are going to pay for their treatment or
face a choice between buying life-saving medications and putting food on the table.
The Inflation Reduction Act of 2022 will lower health care costs for millions of Americans and
put money back in the pockets of American families and seniors. The Act will cap prescription
drug costs for hundreds of thousands of Tennessee Medicare beneficiaries, reduce health
insurance premiums for hundreds of thousands of Tennesseans by about $720 per year on
average while expanding coverage to about 56,000 Tennesseans, and cap insulin co-payments for
the tens of thousands of Tennessee Medicare beneficiaries that use insulin.
Cutting Prescription Drug Costs
Americans pay two to three times what citizens of other countries pay for prescription drugs. For
some drugs, U.S. prices are even higher than that. For example, a GAO study found that Spiriva,
used to control asthma and used by about 700,000 Medicare beneficiaries in 2020, had an
estimated U.S. net price of $250 in 2020 and cost between $30 and $52 in France, Australia and
Canada. Myrbetriq, used to control overactive bladder and used by over 600,000 Medicare
beneficiaries in 2020, had an estimated U.S. net price of $164 and cost $43 in Canada.
The Inflation Reduction Act finally takes on this problem by allowing Medicare to negotiate
prices for high-cost drugs. It also provides seniors and people with disabilities who have
Medicare coverage with new protections against unaffordable prescription drug bills.
• Protecting Hundreds of Thousands of Tennesseans from Catastrophic Drug Costs by
Capping Medicare Beneficiary Out-of-Pocket Costs in Part D at $2,000. Currently,
Medicare beneficiaries with conditions such as cancer, multiple sclerosis, and lung disease
can face thousands of dollars in out-of-pocket prescription drug costs, and millions of people
in Medicare struggle to afford their medications. The Act will require Part D plans to offer
improved financial protections that would phase in starting in 2024, with the $2,000 out-of-
pocket cap taking effect in 2025. Each year, that will benefit about 37,000 Tennessee
Medicare beneficiaries who would otherwise have out-of-pocket costs above the cap,
according to estimates from the Kaiser Family Foundation (KFF). And, for the first time, all
1.1 million Tennesseans with Medicare Part D will have the peace of mind of knowing their
pharmacy costs are capped.
• Saving Billions of Dollars for Seniors and People with Disabilities and the Federal
Government by Allowing Medicare to Negotiate Prices for High-Cost Drugs. By
bringing down the cost of these drugs, the legislation will save billions of dollars for both
Medicare beneficiaries, who will see reduced out-of-pocket costs, and the federal
government. Nationwide, KFF estimates suggest that some 5 to 7 million beneficiaries each
year use the types of high-cost drugs that would be subject to negotiation and could see
reduced cost sharing as a result.